Angiodynamics (ANGO) Accumulated Expenses (2011 - 2026)

Angiodynamics' Accumulated Expenses history runs 16 years deep, the most recent figure standing at $38.9 million for Q2 2026.

• Quarterly Accumulated Expenses rose 9.55% year-over-year to $38.9 million in Q2 2026, while the trailing twelve-month figure through May 2026 was $38.9 million (up 9.55% YoY) and the FY2026 annual result came in at $38.9 million, up 9.55% from the prior year.
• Accumulated Expenses was $38.9 million for Q2 2026 at Angiodynamics, up from $32.3 million in the prior quarter.
• Across five years, Accumulated Expenses topped out at $41.1 million in Q2 2024 and bottomed at $21.8 million in Q1 2023.
• A 5-year average of $31.3 million and a median of $30.4 million in 2024 frame the typical range for Accumulated Expenses.
• Annual changes were most pronounced in 2024 — Accumulated Expenses soared 54.41% — and 2025, when it dropped 25.22%.
• Angiodynamics' Accumulated Expenses stood at $26.5 million in 2022, then grew by 10.19% to $29.2 million in 2023, then surged by 36.54% to $39.9 million in 2024, then fell by 25.22% to $29.9 million in 2025, then jumped by 30.34% to $38.9 million in 2026.
• Business Quant data shows ANGO's Accumulated Expenses at $38.9 million in Q2 2026, $32.3 million in Q1 2026, and $29.9 million in Q4 2025.